Cytokinetics, Incorporated (MIL:1CYTK) Financings
Financings
| Raise | Date |
|---|---|
| 1.75% convertible senior notes due 2031 Made bigger: US$650M Use of proceeds: About $402.5M to exchange 2027 convertible notes; rest for aficamten launch and development, pipeline research and general corporate purposes | Sep 16, 2025 |